• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜下胸交感神经切断术后预后的预测因素。

Predictors of outcome following endoscopic thoracic sympathectomy.

作者信息

Bell David, Jedynak Justin, Bell Roger

机构信息

Department of Vascular Surgery, Monash Medical Centre, Clayton, Victoria, Australia.

出版信息

ANZ J Surg. 2014 Jan-Feb;84(1-2):68-72. doi: 10.1111/ans.12098. Epub 2013 Feb 21.

DOI:10.1111/ans.12098
PMID:23432865
Abstract

BACKGROUND

Endoscopic thoracic sympathectomy (ETS) provides definitive management for primary focal hyperhidrosis and facial blushing. These conditions are debilitating and not uncommon, but many clinicians avoid ETS due to the risk of complications, particularly compensatory sweating (CS). This retrospective cohort study aimed to evaluate the degree of symptom resolution, patient satisfaction and adverse reactions after ETS and to identify subgroups of patients more likely to achieve a satisfactory outcome.

METHODS

From 2004 to 2010, 210 patients underwent ETS performed by a single surgeon. These patients responded to a questionnaire regarding levels of satisfaction, symptom resolution and complications encountered, particularly CS.

RESULTS

Palmar hyperhidrosis (97%) and scalp/facial hyperhidrosis (93%) demonstrated greater degrees of symptom resolution than axillary hyperhidrosis (71%) and facial blushing (71%) (P < 0.001). Rates of severe CS were lowest in patients with palmar hyperhidrosis (8%) and highest in patients with axillary (26%) and scalp/facial (44.5%) hyperhidrosis (P = 0.0003). The probability of experiencing no CS was highest at young ages and decreased with age (P = 0.0006). Satisfaction rates also fell as age increased (P = 0.004). Satisfaction rates were highest in patients with palmar (90%) and lowest in patients with scalp/facial (52%) hyperhidrosis (P < 0.02).

DISCUSSION

Patient satisfaction following ETS is highest among younger patients and those undergoing the procedure for palmar hyperhidrosis. Dissatisfaction arises from failure to achieve the desired aim as well as the development of severe CS, which is more common in older patients and those undergoing ETS for axillary and scalp/facial hyperhidrosis.

摘要

背景

内镜胸交感神经切除术(ETS)为原发性局灶性多汗症和面部潮红提供了确定性治疗。这些病症令人衰弱且并不罕见,但许多临床医生因并发症风险,尤其是代偿性出汗(CS)而避免实施ETS。这项回顾性队列研究旨在评估ETS后症状缓解程度、患者满意度和不良反应,并确定更有可能获得满意结果的患者亚组。

方法

2004年至2010年,210例患者接受了由同一位外科医生实施的ETS。这些患者对一份关于满意度、症状缓解情况和所遇到并发症(尤其是CS)的问卷做出了回应。

结果

手掌多汗症(97%)和头皮/面部多汗症(93%)的症状缓解程度高于腋窝多汗症(71%)和面部潮红(71%)(P < 0.001)。手掌多汗症患者中严重CS的发生率最低(8%),腋窝(26%)和头皮/面部(44.5%)多汗症患者中最高(P = 0.0003)。无CS发生的概率在年轻时最高,并随年龄增长而降低(P = 0.0006)。满意度也随年龄增加而下降(P = 0.004)。手掌多汗症患者的满意度最高(90%),头皮/面部多汗症患者的满意度最低((52%)(P < 0.02)。

讨论

ETS后的患者满意度在年轻患者和接受手掌多汗症手术的患者中最高。不满源于未能达到预期目标以及严重CS的发生,这在老年患者以及接受ETS治疗腋窝和头皮/面部多汗症的患者中更为常见。

相似文献

1
Predictors of outcome following endoscopic thoracic sympathectomy.内镜下胸交感神经切断术后预后的预测因素。
ANZ J Surg. 2014 Jan-Feb;84(1-2):68-72. doi: 10.1111/ans.12098. Epub 2013 Feb 21.
2
Endoscopic thoracic sympathectomy: long-term results for treatment of upper limb hyperhidrosis and facial blushing.内镜下胸交感神经切除术:治疗上肢多汗症和面部潮红的长期结果
Acta Chir Belg. 2011 Sep-Oct;111(5):293-7.
3
Plantar Sweating as an Indicator of Lower Risk of Compensatory Sweating after Thoracic Sympathectomy.足底出汗作为胸交感神经切除术后代偿性出汗风险较低的指标。
Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.
4
Late results of endoscopic thoracic sympathectomy for hyperhidrosis and facial blushing.内窥镜胸交感神经切断术治疗多汗症和面部潮红的远期疗效。
Br J Surg. 2011 Dec;98(12):1719-24. doi: 10.1002/bjs.7682. Epub 2011 Sep 16.
5
[Long-term effects after surgery for hand sweating and facial blushing. Patients are satisfied in spite of troublesome side-effects].[手部多汗症和面部潮红手术后的长期影响。尽管有令人烦恼的副作用,患者仍感到满意]
Lakartidningen. 2001 Apr 11;98(15):1766-72.
6
Treatment of palmar hyperhidrosis: T(4) level compared with T(3) and T(2).手掌多汗症的治疗:T(4)水平与T(3)和T(2)的比较
Ann Surg. 2007 Aug;246(2):330-6. doi: 10.1097/SLA.0b013e3180caa466.
7
Bilateral thoracoscopic sympathectomy: results and long-term follow-up.双侧胸腔镜交感神经切除术:结果与长期随访
Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):67-70. doi: 10.1510/icvts.2007.162479. Epub 2007 Nov 12.
8
Impact of compensatory hyperhidrosis on patient satisfaction after endoscopic thoracic sympathectomy.代偿性多汗症对内镜下胸交感神经切断术后患者满意度的影响。
Neurosurgery. 2009 Mar;64(3):511-8; discussion 518. doi: 10.1227/01.NEU.0000339128.13935.0E.
9
[Thoracoscopic sympathectomy in the treatment of palmar hyperhidrosis and facial blushing].[胸腔镜交感神经切除术治疗手掌多汗症和面部潮红]
Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2795-7.
10
Severity of compensatory sweating after thoracoscopic sympathectomy.胸腔镜交感神经切除术后代偿性多汗的严重程度。
Ann Thorac Surg. 2004 Aug;78(2):427-31. doi: 10.1016/j.athoracsur.2004.02.087.

引用本文的文献

1
Efficacy and Safety of Treatments for Primary Palmar Hyperhidrosis: A Systematic Review Assessing Patient-Centric Outcomes.原发性手掌多汗症治疗的疗效与安全性:一项评估以患者为中心结局的系统评价
Dermatol Res Pract. 2025 Aug 20;2025:8867838. doi: 10.1155/drp/8867838. eCollection 2025.
2
Which patients are more likely to experience compensatory hyperhidrosis after endoscopic thoracic sympathectomy: a meta-analysis and systematic review.哪些患者在内镜下胸交感神经切除术后更易出现代偿性多汗症:一项荟萃分析与系统评价
PeerJ. 2025 Mar 18;13:e19097. doi: 10.7717/peerj.19097. eCollection 2025.
3
Predictors of Compensatory Sweating and Satisfaction Following Endoscopic Thoracic Sympathetic Chain Clipping for Palmar/Axillary Hyperhidrosis.
内镜下胸交感神经链切断术治疗手掌/腋窝多汗症后代偿性出汗及满意度的预测因素
J Clin Med. 2025 Jan 8;14(2):326. doi: 10.3390/jcm14020326.
4
Can we predict the compensatory hyperhidrosis following a thoracic sympathectomy?我们能否预测胸交感神经切除术后的代偿性多汗症?
Indian J Thorac Cardiovasc Surg. 2019 Apr;35(2):190-195. doi: 10.1007/s12055-018-0769-1. Epub 2018 Dec 14.
5
Thoracic sympathectomy for hyperhidrosis: from surgical indications to clinical results.胸交感神经切除术治疗多汗症:从手术适应症到临床结果
J Thorac Dis. 2017 Apr;9(Suppl 3):S178-S192. doi: 10.21037/jtd.2017.04.04.
6
Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review.优化治疗手掌多汗症的交感神经链水平的靶向治疗:更新的系统评价。
Surg Endosc. 2017 Nov;31(11):4357-4369. doi: 10.1007/s00464-017-5508-y. Epub 2017 Apr 7.
7
Long-term results of oxybutynin use in treating facial hyperhidrosis.使用奥昔布宁治疗面部多汗症的长期效果。
An Bras Dermatol. 2014 Nov-Dec;89(6):912-6. doi: 10.1590/abd1806-4841.20143272.
8
Management of hyperhidrosis.多汗症的治疗。
Clin Cosmet Investig Dermatol. 2014 Oct 29;7:285-99. doi: 10.2147/CCID.S53119. eCollection 2014.